Linda P. Briley

The Population Reference Sample, POPRES: A Resource for Population, Disease, and Pharmacological Genetics Research

Matthew R. Nelson, Katarzyna Bryc, Karen S. King et al. · The American Journal of Human Genetics · 2008 · 332 citations · Full text

Genetic Analysis, Pharmacological Genetics Research, Genotype-phenotype Association +11

<i>HLA-DQA1</i> * <i>02:01</i> Is a Major Risk Factor for Lapatinib-Induced Hepatotoxicity in Women With Advanced Breast Cancer

Colin F. Spraggs, L. R. Budde, Linda P. Briley et al. · Journal of Clinical Oncology · 2011 · 274 citations

Genomewide Search for Type 2 Diabetes Susceptibility Genes in Four American Populations

Margaret G. Ehm, Maha Karnoub, H. Sakul et al. · The American Journal of Human Genetics · 2000 · 194 citations · Full text

Genome-wide Association Study, Genetic Determinant, Diabetes Epidemiology +10

<i>HLA-B</i> *57:01 Confers Susceptibility to Pazopanib-Associated Liver Injury in Patients with Cancer

Chun‐Fang Xu, Toby Johnson, Xiaojing Wang et al. · Clinical Cancer Research · 2015 · 95 citations · Full text

Comprehensive genome-wide evaluation of lapatinib-induced liver injury yields a single genetic signal centered on known risk allele HLA-DRB1*07:01

Laura R. Parham, Linda P. Briley, L Li et al. · The Pharmacogenomics Journal · 2015 · 60 citations · Full text